BGV (BioGeneration Ventures)
- United Kingdom
- Ireland
- Pre-Seed
- Seed
- Consumer Health
- Pharmaceuticals
- Biotech
- Health & Hospital Services
- Digital Health
BioGeneration Ventures (BGV) is a venture capital firm specializing in earlystage life sciences investments. They leverage extensive sector expertise and a robust network to support the growth of innovative biotech companies across Europe.
Investment Thesis
Team
Investment Team:
Edward van Wezel – Managing Partner
Oskar Slotboom – Managing Partner
Daniela Couto
PhD – General Partner
Keno Gutierrez
PhD – General Partner
Diede Brunen
PhD – Principal
Venture Partners:
Rob de Ree – Venture Partner
Arnoud Dijkstra
PhD – Venture Partner
Wouter Verhoeven – Venture Partner
Alexander Vos – Venture Partner
Elena Ritsou
PhD – Venture Partner
Advisors:
Arnon Kater – Senior Advisor
Emile Voest – Senior Advisor
Roger Ulrich – Senior Advisor
John J.P. Kastelein
MD PhD FESC – Senior Advisor
Jeff Sharman
MD – Senior Advisor
Operations:
Robbert van de Griendt – Head of Investment Relations
Cyril Lesser – Senior Controller
Laura Asbjornsen
LLM
MBA – Head of Communications
Machteld Groeneveld
LLM
EMBA – Legal Counsel & Compliance Officer
Patricia Vonk – AML/KYC Manager
Administration and Support:
Dragana Dragusin – Executive Assistant
Olga Ziessen – Manager Secretarial Services
Portfolio
Artica Therapeutics
Azafaros
Brenig
Catalym
Citryll
Complement Therapeutics
Confo Therapeutics
Dualyx
Dunad
Fibrocor
FundaMental Pharma
Genase Therapeutics
Mironid
NorthSea Therapeutics
Phlox
Phosphoenix
RhyGaze
Scenic Biotech
Tessellate Bio
Tiga Tx
VarmX
VectorY